FAM21A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.514800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.268220E-01
Normal-vs-Stage2
2.790200E-01
Normal-vs-Stage3
1.081570E-01
Normal-vs-Stage4
4.203200E-01
Stage1-vs-Stage2
4.911800E-01
Stage1-vs-Stage3
4.507000E-01
Stage1-vs-Stage4
5.768400E-01
Stage2-vs-Stage3
1.963790E-01
Stage2-vs-Stage4
9.890200E-01
Stage3-vs-Stage4
3.271800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.063400E-01
Normal-vs-AfricanAmerican
7.491200E-01
Normal-vs-Asian
3.631000E-01
Caucasian-vs-AfricanAmerican
1.924490E-02
Caucasian-vs-Asian
7.986000E-01
AfricanAmerican-vs-Asian
1.257200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.390200E-01
Normal-vs-Female
2.768400E-01
Male-vs-Female
8.826000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.852800E-01
Normal-vs-Age(41-60Yrs)
4.424000E-01
Normal-vs-Age(61-80Yrs)
2.044400E-01
Normal-vs-Age(81-100Yrs)
1.379580E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.122800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.178400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.605400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.266300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.747600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.180800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.123350E-01
Normal-vs-Daily Drinker
2.630600E-01
Normal-vs-Weekly Drinker
5.051800E-01
Normal-vs-Occasional Drinker
2.150600E-01
Normal-vs-Social Drinker
8.387800E-01
Non Drinker-vs-Daily Drinker
6.245200E-01
Non Drinker-vs-Weekly Drinker
2.637800E-01
Non Drinker-vs-Occasional Drinker
5.091200E-01
Non Drinker-vs-Social Drinker
1.823600E-02
Daily Drinker-vs-Weekly Drinker
5.467400E-01
Daily Drinker-vs-Occasional Drinker
8.956000E-01
Daily Drinker-vs-Social Drinker
9.818400E-02
Weekly Drinker-vs-Occasional Drinker
6.054200E-01
Weekly Drinker-vs-Social Drinker
3.857600E-01
Occasional Drinker-vs-Social Drinker
1.043780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.829600E-01
Normal-vs-Grade 2
2.103200E-01
Normal-vs-Grade 3
2.298000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.894300E-02
Grade 1-vs-Grade 3
6.155500E-02
Grade 1-vs-Grade 4
4.829600E-01
Grade 2-vs-Grade 3
6.089800E-01
Grade 2-vs-Grade 4
2.103200E-01
Grade 3-vs-Grade 4
2.298000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.160800E-01
Normal-vs-NonDiabetic
1.662620E-01
Diabetic-vs-NonDiabetic
2.098200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.611000E-01
Normal-vs-NoPancreatitis
2.110400E-01
Pancreatitis-vs-NoPancreatitis
4.191200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.827400E-01
Normal-vs-N1
2.358800E-01
N0-vs-N1
5.574600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.633170E-01
Normal-vs-TP53-NonMutant
2.139400E-01
TP53-Mutant-vs-TP53-NonMutant
7.108800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
